The Synthetic Androgen Methyltrienolone (R1881) Acts as a Potent Antagonist of the Mineralocorticoid Receptor

@article{Takeda2007TheSA,
  title={The Synthetic Androgen Methyltrienolone (R1881) Acts as a Potent Antagonist of the Mineralocorticoid Receptor},
  author={Armelle-Natsuo Takeda and Gr{\'e}gory Maurice Pinon and Marcelle Bens and J{\'e}r{\^o}me Fagart and Marie-Edith Rafestin-Oblin and Alain Vandewalle},
  journal={Molecular Pharmacology},
  year={2007},
  volume={71},
  pages={473 - 482}
}
Aldosterone binds to the mineralocorticoid receptor (MR) and exerts fine control over Na+ absorption in renal collecting duct cells (CCDs). Many natural and synthetic steroids can also bind to the MR to produce agonist or antagonist effects. Here, we investigate whether androgenic hormones act as MR agonist or antagonist ligands in CCDs. Testosterone (T), dihydrotestosterone (DHT), and methyltrienolone (R1881), a synthetic androgen agonist, all bind to the MR. R1881 displayed the same affinity… Expand
Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites
TLDR
Tibolone by these actions on different receptors and by this capacity to transform in different metabolites, has more complex effects than initially supposed. Expand
Compound Profiling Using a Panel of Steroid Hormone Receptor Cell-Based Assays
TLDR
These cell-based steroid hormone receptor assays provide good selectivity, sensitivity, and appropriate pharmacology for high-throughput screening and selectivity profiling of modulators of steroid hormone receptors. Expand
The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology
TLDR
The structure, molecular mechanism of action and transcriptional regulation mediated by MR are described, emphasizing the most recent developments at the cellular and molecular level. Expand
Aldosterone, mineralocorticoid receptor, and heart failure
TLDR
Experimental and clinical data clearly highlight the deleterious cardiovascular effects of MR stimulation, and the importance of this receptor in cardiovascular tissue. Expand
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain
TLDR
This review aims to present and comprehensively discuss molecules that affect AR signaling through direct or indirect interactions with the AR‐TAD or the DBD, and highlights the significant in vitro and in vivo data found for each compound and the apparent limitations and/or potential for further development of these agents as PCa therapies. Expand
Metabolic modulation induced by oestradiol and DHT in immature rat Sertoli cells cultured in vitro.
TLDR
The results support the existence of a relation between sex hormones action and energy metabolism, providing an important assessment of androgens and oestrogens as metabolic modulators in rat Sertoli cells. Expand
Medicinal Use of Testosterone and Related Steroids Revisited
TLDR
Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. Expand
A High-Content Glucocorticoid Receptor Translocation Assay for Compound Mechanism-of-Action Evaluation
TLDR
The authors have developed a robust assay system for the glucocorticoid receptor (GR) that was applied to a panel of nuclear receptor ligands and quantified and a correlation with other conventional assays established. Expand
The Endothelial Mineralocorticoid Receptor: Contributions to Sex Differences in Cardiovascular Disease.
TLDR
Enhanced understanding of the sex-specific roles of endothelial MR could lead to novel mechanistic insights underlying sex differences in cardiovascular disease incidence and outcomes and could identify additional therapeutic targets to effectively treat cardiovascular disease in men and women. Expand
Emerging roles of the ubiquitin-proteasome system in the steroid receptor signaling
TLDR
It is emphasized that the deep mechanistic connections between AR and ER-dependent transcription and the UPS for the correct expression of target genes has a significant potential for future clinical application, including the treatment of breast and prostate cancers by facilitating the degradation of related hormone receptors. Expand
...
1
2
...

References

SHOWING 1-10 OF 57 REFERENCES
11β-Hydroxyprogesterone Acts as a Mineralocorticoid Agonist in Stimulating Na+ Absorption in Mammalian Principal Cortical Collecting Duct Cells
TLDR
It is demonstrated that in the absence of the 21-hydroxyl group, the 11β-hydroxyyl group can produce the contact with the hMR-Asn770 required for the h MR activation leading to stimulated Na + absorption. Expand
Specific Recognition of Androgens by Their Nuclear Receptor
TLDR
A homology model of the ligand-binding domain (LBD) of the human androgen receptor (hAR) was constructed based on the progesterone receptor LBD crystal structure, which suggests new directions for drug design. Expand
Androgen receptor antagonists (antiandrogens): structure-activity relationships.
TLDR
There is a need for next-generation antiandrogens, which could display an equal or even higher affinity for AR compared to the natural androgens, and at the same time maintain its pure antiandrogenic activity, and thus providing improved androgen blockade using possibly anti androgens alone. Expand
Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor
TLDR
The results suggest that ligand binding kinetics and ligand dependent modification in receptor structure are important modulators of MR function as a transcriptional regulatory factor. Expand
Affinity of corticosteroids for mineralocorticoid and glucocorticoid receptors of the rabbit kidney: effect of steroid substitution.
Corticosteroid derivatives coupled in the C3, C7 or C17 position with a long aliphatic chain were synthesized in order to select a suitable ligand for the preparation of a biospecific affinityExpand
Antagonism in the human mineralocorticoid receptor
TLDR
A new mechanism of antagonism is proposed in which the AF2‐AD core region is destabilized by the loss of contacts between the antagonist and the helix H12 region, proposed in the light of the hMR homology model. Expand
Testosterone: a specific competitive antagonist of aldosterone in the toad bladder.
TLDR
It is concluded that testosterone is a specific competitive antagonist of aldosterone, and [3H]aldosterone nuclear and cytoplasmic binding sites could be mineralocorticoid receptors, mediating the action of a Aldosterone on Na+ transport. Expand
The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms.
TLDR
The coregulator and corepressor interactions with the mineralocorticoid receptor (MR) indicate that MR ligand binding domain (LBD) interacts strongly with only a few specific coactivator peptides in the presence of the agonist aldosterone and that these interactions are blocked by the antagonist eplerenone. Expand
Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor.
TLDR
The results support the idea that a short sequence upstream of the LBD is essential for the interaction of hMR with hsp90 and that the C terminus of h MR and hSp90 are both essential for folding of the receptor in a high-affinity hormone-binding state. Expand
RU-26988--a new tool for the study of the mineralocorticoid receptor.
TLDR
RU-26988 is a recently synthesized glucocorticoid that shows very low affinity for the mineralocortioid receptor and has over twice the ability of unlabeled dexamethasone to compete with [3H]dexameth asone for binding to the renal cytosol glucoc Corticoid receptor. Expand
...
1
2
3
4
5
...